's fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX
) again, after disclosing a buy of around 360,700 shares a couple of days ago
. This time, Perceptive acquired 155,000 shares, bringing the position to a total of some 6.37 million shares. The average purchase price amounts to around $6.87 per share.
Heartland Advisors Discloses Changes in its Albany International and Gulf Island Holdings
Bill Ackman Cuts Stake in LSE-listed Platform Specialty Products
Chuck Royce Discloses Moves in Vera Bradley, Graham Corp & Others